Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Profit After Tax (2016 - 2025)

DarioHealth filings provide 13 years of Profit After Tax readings, the most recent being -$9.0 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 6.24% to -$9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$41.7 million, a 2.42% increase, with the full-year FY2025 number at -$41.7 million, up 2.42% from a year prior.
  • Profit After Tax hit -$9.0 million in Q4 2025 for DarioHealth, up from -$10.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$7.2 million in Q1 2024 to a low of -$22.4 million in Q3 2021.
  • Median Profit After Tax over the past 5 years was -$13.9 million (2023), compared with a mean of -$14.1 million.
  • Biggest five-year swings in Profit After Tax: plummeted 343.46% in 2021 and later surged 44.05% in 2024.
  • DarioHealth's Profit After Tax stood at -$21.6 million in 2021, then surged by 41.55% to -$12.6 million in 2022, then fell by 13.22% to -$14.3 million in 2023, then soared by 32.57% to -$9.6 million in 2024, then grew by 6.24% to -$9.0 million in 2025.
  • The last three reported values for Profit After Tax were -$9.0 million (Q4 2025), -$10.5 million (Q3 2025), and -$13.0 million (Q2 2025) per Business Quant data.